Anaplastic thyroid carcinoma
University of California, San Francisco · UCSF Helen Diller Family Comprehensive Cancer Center
Abstract
Anaplastic thyroid carcinoma (ATC) is rare but is one of the most aggressive human malignancies. Several prognostic factors have been observed in patients with ATC, and some experts advocate aggressive multimodal therapy in selected patients. However, it is unclear whether such an approach significantly improves survival. The authors analyzed prognostic factors and treatment outcomes in patients with ATC reported in the National Cancer Institute's Surveillance, Epidemiology, and End Results data base.
The cohort consisted of 516 patients with ATC reported to 12 population-based cancer registries between 1973 and 2000. Demographic, pathologic, and treatment data were used for univariate and multivariate survival analyses.
Citation impact
- FWCI
- 11.34
- Percentile
- 100%
- References
- 38
Authors
5- EKElectron KebebewCorresponding
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- FSFrancis S. Greenspan
University of California, San Francisco
- OHOrlo H. Clark
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- KAKenneth A. Woeber
University of California, San Francisco
- AMAlex McMillan
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
Topics & keywords
- Medicine
- Radiation therapy
- Univariate analysis
- Multivariate analysis
- Thyroid cancer
- Population
- Thyroid
- Cancer
- Good health and well-being